Ventana Medical Systems' (Ventana) CONFIRM anti-Calretinin (SP65) Rabbit Monoclonal Primary Antibody (CONFIRM anti-Calretinin (SP65)) is directed against the calcium binding protein, calretinin, expressed by normal and reactive mesothelium, eccrine glands of skin, Sertoli cells of the testis, ovarian stromal cells and adrenal cortical cells. This antibody exhibits a nuclear and cytoplasmic staining pattern and may be used to aid in the identification of mesothelioma, and in distinguishing mesothelioma from adenocarcinoma. The antibody is intended for qualitative staining in sections of formalin-fixed, paraffin-embedded tissue.
This product should be interpreted by a qualified pathologist in conjunction with histological examination, relevant clinical information, and proper controls.
This antibody is intended for in vitro diagnostic (IVD) use.